Novartis Foundation

Recent papers from Novartis Foundation

1. Understanding and predicting CVD in Singapore: socioeconomic determinants and a non-lab risk score across two cohortsEuropean Heart Journal · 2026
2. Safety and efficacy of lacnotuzumab, a colony-stimulating factor 1 antibody for the treatment of tenosynovial giant cell tumors: a randomized phase II trialScientific Reports · 2026
3. Using Machine Learning to Identify Social Risk Factors of Hypertension and Diabetes in New York City: Evidence to Support the HealthyNYC InitiativeJournal of the American Heart Association · 2026
4. A General Workflow for Tangential Flow Filtration Perfusion Scale‐UpBiotechnology and Bioengineering · 2026
5. The influence of silicon on growth, drought stress tolerance and defense against Neopestalotiopsis lusitanica, in Eucalyptus globulusFrontiers in Plant Science · 2026
6. Mitigation of pesticide residues in rice: influence of cooking methods on long-grain, brown, and Basmati varietiesFood Additives & Contaminants Part A · 2026
7. Supporting crop yields under climate change by engineering innate soil microbiomesApplied and Environmental Microbiology · 2026
8. BRD9 Degraders Unleash GBAF Chromatin Remodeling Activity in Synovial SarcomaCancer Research · 2026
9. A Machine Learning Approach to Prioritize Place-Based Prevention to Address Cardiovascular Disease Burden in New York CityAmerican Journal of Preventive Medicine · 2026
10. Estimation of Future Patient Populations Eligible for Radioligand Therapies in the EU and the UK: A Modelling StudyThe Lancet Regional Health - Europe · 2026
11. Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE TrialClinical Cancer Research · 2026
12. Letter to the Editor of the British Journal of Clinical Pharmacology Re: van Iersel et al. (2026)—Why do healthy volunteers participate in clinical trials? doi: https://doi.org/10.1002/bcp.70499British Journal of Clinical Pharmacology · 2026
13. Clinical Development of Novel-Novel Multi-Company Combination Therapies in Oncology.2026
14. Socioeconomic and Behavioral Inequalities in Cardiovascular HealthJACC Asia · 2026
15. Cassava production systems optimized for double output: Seed‐cuttings and root yieldsAgronomy Journal · 2026
16. CARDIO4Cities: A Roadmap for Improving Urban Cardiovascular HealthAmerican Journal of Preventive Cardiology · 2026
17. Hypertension management in São Paulo: insights from a computational simulation approachThe Lancet Regional Health - Americas · 2026
18. CARDIO4Cities: from global evaluation framework to local monitoring in Dakar and São PauloBMC Public Health · 2026
19. Beyond inclusion: are clinical trials solving the right problem?Trials · 2026
20. COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant MelanomaCancers · 2026